Arvinas (ARVN) Return on Invested Capital (2023 - 2024)
Arvinas' (ARVN) quarterly Return on Invested Capital came in at 14.93% in Q2 2024, up 611.0% year-on-year from 2.1% in Q3 2023, and down 31.05% quarter-over-quarter from 11.39% in Q1 2024.
Arvinas (ARVN) Return on Invested Capital (2023 - 2024) Analysis & Trends
Arvinas' Return on Invested Capital history runs 2 years deep, the most recent figure standing at 14.93% for Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Arvinas | 519.68 Mn | -95.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -14.93% |
| Mar 31, 2024 | -11.39% |
| Dec 31, 2023 | -10.06% |
| Sep 30, 2023 | -10.77% |
| Jun 30, 2023 | -21.04% |